President Trump Signs Law Creating Diabetes Commission
President Trump signs law creating diabetes commission Please provide your email address to receive an email when new articles are posted on this topic. Receive an email when new articles are posted on this topic. President Donald Trump last week signed new legislation that calls for the creation of a national commission of health care experts to address issues related to diabetes care, including closing any gaps in federal support efforts and finding opportunities for consolidation. The legislation, which calls for the establishment of a 23-member commission to optimize programs for Americans with diabetes , was champions by the American Association of Clinical Endocrinologists, who have supported the bipartisan initiative since it was first introduced in the U.S. House of Representatives in September 2011. The bill was authored by Sens. Jeanne Shaheen, D-NH and Susan Collins, R-ME. We are so excited to finally see the passage of this legislation to improve the quality of care of patients with diabetes, Jonathan Leffert, FACP, FACE, ECNU, president of AACE, told Endocrine Today. AACE committed to leading this legislation through the Congress because as clinical endocrinologists, we recognized the gaps in translation between research and clinical care. The Commission will focus on developing solutions to bring the outstanding research and education in diabetes accomplished by the federal government to clinicians and patients with this complex disease. S. 920, the "National Clinical Care Commission Act," establishes a National Clinical Care Commission within the Department of Health and Human Services to evaluate and make recommendations on the use of federal resources in combating diabetes , according to a press release issued by the White House Nov. 2. The commission Continue reading >>
S. 920, National Clinical Care Commission Act
S. 920, National Clinical Care Commission Act On Tuesday, October 10, 2017, the House will begin consideration of S. 920 , National Clinical Care Commission Act, under suspension of the rules. S. 920 was introduced on April 24, 2017, by Senator Jeanne Shaheen (D-NH) and passed the Senate by Unanimous Consent on September 6, 2017. S. 920 establishes a clinical care commission to evaluate and recommend solutions regarding better coordinating federal programs related to complex metabolic or autoimmune disorders, a disease resulting from insulin deficiency or resistance, or complications caused by any such disease. The bill requires the Commission to report its recommendations not later than three years after its first meeting. The bill sunsets the Commission at the end of fiscal year 2021. The federal government supports research and development (R&D) that is conducted by a wide variety of performers, including federally owned and operated laboratories, universities, private companies, and other research institutions. This includes funding for the National Institutes of Health (NIH), which is the focal point for federal health research. An agency of the Department of Health and Human Services (HHS), it uses its $30 billion plus budget to support more than 300,000 scientists and research personnel working at over 2,500 institutions across the United States and abroad, as well as to conduct biomedical and behavioral research and research training at its own facilities. H.R. 1192 will establish a commission that will attempt to better utilize existing federal funding for complex metabolic or autoimmune disorders including diabetes, which includes some funding administered by NIH. In the 115th Congress, the House passed similar legislation ( H.R. 309 ) by voice vote on Januar Continue reading >>
The National Clinical Care Commission Act: An Initiative To Improve Diabetes Care
The National Clinical Care Commission Act: An Initiative to Improve Diabetes Care At the beginning of November 2017, S. 920/ HR 309, a bipartisan bill to establish the National Clinical Care Commission, was signed into law. The commission will consist of a representative from eleven different government agencies, as well as members from the private sector. The main goals of the commission will be to gather the most up-to-date, comprehensive information about diabetes in order to provide guidance on making improvements to basic and clinical research, medical treatment, and patient outreach and education initiatives. The commission members will be of diverse backgrounds and will include representatives from major agencies such as the Food and Drug Administration, the National Institutes of Health, the Centers for Disease Control and Prevention, the Department of Defense, and the Department of Agriculture. Agencies representing minorities, including the Indian Health Service and the Office of Minority Health will also be involved. The Center for Medicare & Medicaid Services, The Agency for Healthcare Research and Equality, The Department of Veterans Affairs, and The Health Resources and Services Administration round out the agencies that will participate. In addition, private sector members that remain to be determined will include medical practitioners such as clinical endocrinologists, patient advocates, and various other experts. The commission will submit a report detailing their specific goals and initiatives, as well as a list of any additional members and agencies that will be involved to help achieve the objectives within 90 days of their first meeting. The commission will meet two to four times annually and will submit a final report after three years, at the end Continue reading >>
National Diabetes Clinical Care Commission Act (2015; 114th Congress S. 586) - Govtrack.us
Were looking to learn more about who uses GovTrack and what features you find helpful or think could be improved. If you can, please take a few minutes to help us improve GovTrack for users like you. Im a lobbyist, advocate, or other professional. Im a young person (younger than 26 years old). Im a member of a minority or disadvantaged group. Im a teacher, librarian, or other educator. We hope to make GovTrack more useful to policy professionals like you. Please sign up for our advisory group to be a part of making GovTrack a better tool for what you do. Young Americans have historically been the least involved in politics, despite the huge consequences policies can have on them. By joining our advisory group, you can help us make GovTrack more useful and engaging to young voters like you. Our mission is to empower every American with the tools to understand and impact Congress. We hope that with your input we can make GovTrack more accessible to minority and disadvantaged communities who we may currently struggle to reach. Please join our advisory group to let us know what more we can do. We love educating Americans about how their government works too! Please help us make GovTrack better address the needs of educators by joining our advisory group. Would you like to join our advisory group to work with us on the future of GovTrack? Thank you for joining the GovTrack Advisory Community! Well be in touch. Continue reading >>
- A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC’s National Diabetes Prevention Program
- Carmel Valley resident joins more than 180 diabetes advocates for the American Diabetes Associations 2017 Call to Congress Advocacy Day
- American Diabetes Association calls on Congress to hold hearings on insulin prices
Federal Register :: Establishment Of The National Clinical Care Commission And Solicitation Of Nominations For Commission Members
Establishment of the National Clinical Care Commission and Solicitation of Nominations for Commission Members Information about this document as published in the Federal Register. Nominations must be received no later than close of business May 29, 2018. This tables of contents is a navigational tool, processed from the headings within the legal text of Federal Register documents. This repetition of headings to form internal navigation links has no substantive legal effect. This feature is not available for this document. This feature is not available for this document. These tools are designed to help you understand the official document better and aid in comparing the online edition to the print edition. These markup elements allow the user to see how the document follows the Document Drafting Handbook that agencies use to create their documents. These can be useful for better understanding how a document is structured but are not part of the published document itself. More information and documentation can be found in our developer tools pages . This PDF is the current document as it appeared on Public Inspection on 04/25/2018 at 08:45 am. If you are using public inspection listings for legal research, you should verify the contents of the documents against a final, official edition of the Federal Register. Only official editions of the Federal Register provide legal notice to the public and judicial notice to the courts under 44 U.S.C. 1503 & 1507 . Learn more here . This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format. Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, Office of the Secretary, U.S. Department of Health and Human Services Continue reading >>
S. 920, National Clinical Care Commission Act
S. 920, National Clinical Care Commission Act S. 920 would establish a National Clinical Care Commission within the Department of Health and Human Services (HHS) to evaluate federal programs related to clinical care for individuals with a complex metabolic or autoimmune disease such as diabetes. Commission members would include medical professionals, advocates, and representatives from many agencies within HHS, the Department of Veterans Affairs, the Department of Defense, and the Department of Agriculture. Within three years of convening, the Commission would be required to issue a report on its findings that includes suggested improvements for federally-funded clinical and educational initiatives focused on the targeted populations. Based on an analysis of information provided by HHS, CBO estimates that implementing S. 920 would require the equivalent of about 3 employees each year, on average. This estimate reflects the staff time and other resources necessary to convene the Commission, to provide ongoing support to its mission, and to prepare its final report. CBO estimates that those employees would cost about $2 million over the 2017-2022 period. Such spending would be subject to the availability of appropriated funds. Enacting S. 920 would not affect direct spending or revenues; therefore, pay-as-you-go procedures do not apply. CBO estimates that enacting S. 920 would not increase net direct spending or on-budget deficits in any of the four consecutive 10-year periods beginning in 2028. The bill contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act and would impose no costs on state, local, or tribal governments. Continue reading >>
Call For Nominations For The New National Clinical Care Commission!
Call for Nominations for the New National Clinical Care Commission! ODPHP recently established the National Clinical Care Commission to consider complex metabolic or autoimmune diseases that result from insulin-related issues and represent a significant disease burden in the United States. The Commission will consist of both federal and non-federal members who will provide recommendations to the Secretary and Congress on coordination and leveraging of federal programs related to these issues. ODPHP is currently seeking nominations for non-federal Commission members. Interested individuals should submit a complete nomination package that includes: A letter of nomination that clearly states the nominees name and affiliation, the basis for the nomination, and a statement from the nominee that indicates that the individual is willing to serve as a member of the Commission A 1-page biography that describes the nominees qualifications and, if applicable, highlights relevant experience serving on other Federal Advisory Committees The nominators name, address, and daytime telephone number The address, telephone number, and email address of the individual being nominated The nominees curriculum vitae or resume, limited to no more than 30 pages For more information, or if interested in submitting a nomination, please see the official notice posted in the Federal Register . Sign up for email updates to receive announcements about the Commission, including information about in-person and virtual meeting dates. Continue reading >>
S.920 - 115th Congress (2017-2018): National Clinical Care Commission Act | Congress.gov | Library Of Congress
(This measure has not been amended since it was passed by the Senate on September 6, 2017. The summary of that version is repeated here.) (Sec. 2) This bill establishes within the Department of Health and Human Services (HHS) a National Clinical Care Commission to evaluate and make recommendations regarding improvements to the coordination and leveraging of federal programs related to complex metabolic or autoimmune diseases that result from issues related to insulin and represent a significant disease burden (e.g., diabetes). The commission must report on: (1) HHS programs that focus on prevention, (2) current activities and gaps in federal efforts to support clinicians in providing integrated care, (3) improvement in federal education and awareness activities related to prevention and treatment, (4) methods for outreach and dissemination of education and awareness materials, and (5) opportunities for consolidation of overlapping federal programs. The commission must submit an operating plan to HHS and Congress within 90 days of its first meeting. The commission is terminated after it submits a final report, but not later than the end of FY2021. Continue reading >>
Endobreak: National Clinical Care Commission Act Passed; Reversing T2d?
EndoBreak: National Clinical Care Commission Act Passed; Reversing T2D? News and commentary from the endocrinology world by Kristen Monaco, Staff Writer, MedPage Today This article is a collaboration between MedPage Today and: The American Association of Clinical Endocrinologists' signature bill -- the National Clinical Care Commission Act -- was officially signed into law by President Trump. The legislation is aimed at providing improved access to quality diabetes-related care to patients. The FDA just launched a free, online continuing education course for healthcare providers to help reduce hypoglycemia events in their type 2 diabetes patients. Women with polycystic ovary syndrome (PCOS) should be routinely screened for mental health disorders, researchers suggested at the Society for Endocrinology's annual meeting in Harrogate, England, this week. The study found that women with PCOS were more likely to be diagnosed with depression, anxiety, and bipolar disorder, and to develop attention-deficit/hyperactivity disorder or autism. The Endocrine Society released a new scientific statement on the development and types of diabetic microvascular disease . "The latest research shows that maintaining tight control over blood sugar levels and blood pressure can help to reduce the risk of complications such as diabetic retinopathy," said task force chair Eugene Barrett, MD, PhD, of the University of Virginia in Charlottesville, in a press release. (The Journal of Clinical Endocrinology & Metabolism) After dismal sales of flibanserin (Addyi) -- the female libido treatment approved in 2015 -- the current owner, Valeant Pharmaceuticals, announced plans to give it back to the investor group that originally developed the agent in exchange for a 6% royalty starting 18 months after Continue reading >>
Summary Of S. 539 (113th): National Diabetes Clinical Care Commission Act - Govtrack.us
Add a note about this bill. Your note is for you and will not be shared with anyone. Because you are a member of panel, your positions on legislation and notes below will be shared with the panel administrators. ( More Info ) The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress. 3/12/2013--Introduced.National Diabetes Clinical Care Commission Act - Establishes within the Department of Health and Human Services (HHS) the National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that relate in any way to supporting appropriate clinical care for people with pre-diabetes and diabetes. Sets forth the duties of the Commission, which shall include: (1) evaluating HHS programs, (2) identifying current activities and critical gaps in federal efforts to support clinicians in providing care to people with pre-diabetes and diabetes, (3) recommending how an outcomes-based registry may be developed and then used to evaluate various care models and methods, (4) evaluating and expanding education and awareness to health care professionals regarding clinical practices for the prevention of diabetes and the precursor conditions of diabetes, and (5) reviewing and recommending appropriate methods for outreach and dissemination of educational resources related to diabetes prevention and treatments. Requires the Commission to submit an operating plan to the Secretary and Congress within 90 days of its first meeting. Were looking to learn more about who uses GovTrack and what features you find helpful or think could be improved. If you can, please take a few minutes to help us improve GovTrack for users like you. Im a lobbyist, advo Continue reading >>
National Clinical Care Commission: Laser-like Review Of Diabetes Programs, Policies
National Clinical Care Commission: Laser-like Review of Diabetes Programs, Policies Legislation to improve diabetic health, whether through better management of the governments resources or to appropriate funds to support public health institutions, has been having a rough go of it lately. As far back as 2011, Congressman Pete Olson (R-TX) and Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME) have championed legislation to create an office within the federal public health apparatus to focus exclusively on fostering diabetes research and improving access to quality care. Last fall, in the 115th Congress, they succeeded, with final passage in the House on October 11 of Senate Bill 920, signed into law on November 2, tasking a panel of public health officials and diabetes care experts to examine existing prevention and treatment programs in search of greater efficiency and effectiveness. The final bill reflected changes that had been negotiated in committees of both chambers and in the conference to agree to the Senate amendment. Adopting the changes restating the Commissions task to review programs serving those with complex metabolic or autoimmune diseases, striking Diabetes from the Commissions name, and no longer limiting the non-government officer membership to clinical endocrinologists and related physician specialties cannot be distilled from the committee reports or the Congressional Record. Health care professionals we consulted in preparation of this story either saw the changes as distinctions without a difference or possibly the result of compromises to disarm opponents. In search of the rationale, we reached out in December and again in January to Collins, Olson, and Shaheen staff members. Senator Shaheens policy staff told us this: Regarding the bills Continue reading >>
Dietitians And The National Diabetes Clinical Care Commission
We use cookies to optimize and personalize your experience, provide relevant content and analyze online traffic. We also share information with our analytics and website partners, who may use it to inform decisions about current or future services. By clicking agree, you consent to use cookies if you continue to our website. You can manage your cookie settings by clicking the "cookie preferences" button. We use cookies to optimize and personalize your experience, provide relevant content and analyze online traffic. We also share information with our analytics and website partners, who may use it to inform decisions about current or future services. By clicking Agree below, you consent to use cookies if you continue to our website. You can customize your cookie preferences by using the settings next to "Analytical Cookies" and "Marketing Cookies." Click the "Save Preferences" button to save your customized settings. You can access and change your cookie preferences at any time by clicking "Data Protection Settings" icon in the lower left corner of our website. For more detailed information on the cookies we use, please visit the Academy's Privacy Policy . Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be displayed by changing your browser preferences. Analytical cookies help us to improve our website by collecting and reporting information on its usage. We use some social sharing plugins, to allow you to share certain pages of our website on social media. These plugins place cookies so that you can correctly view how many times a page has been shared. Continue reading >>
American Diabetes Association
What if our federal government could use existing resources to more effectively fight diabetes? Join the American Diabetes Association in urging Congress to support legislation which could turn that idea into reality! The National Diabetes Clinical Care Commission Act (H.R. 1074/S. 539), supported by both Republicans and Democrats, would enable over 30 federal offices with existing diabetes-related programs to better coordinate with each other and the diabetes community. Just two minutes of your time will allow you to tell Congress to use your tax dollars more efficiently to Stop Diabetes! To help the government more effectively fight diabetes, this legislation creates a commission of people with the greatest stake in diabetes to review federal diabetes activities, determine which programs are working and which are not, and recommend new approaches to improve diabetes care. This will ultimately lead to a better quality of life for those facing diabetes. Ask your Member of Congress to co-sponsor the National Diabetes Clinical Care Commission Act. Diabetes is such a big problem that we need to have everyone working together to fight it! You and your family are taking on the challenges of diabetes every day. Now its Congress turn. Managing Director, Federal Government Affairs Continue reading >>
- American Diabetes Association® Releases 2018 Standards of Medical Care in Diabetes, with Notable New Recommendations for People with Cardiovascular Disease and Diabetes
- Diabetes and Hypertension: A Position Statement by the American Diabetes Association
- Solera Health and the American Diabetes Association® Collaborate to Help Prevent and Delay Type 2 Diabetes for Millions of Americans
National Diabetes Clinical Care Commission Act (2013; 113th Congress H.r. 1074) - Govtrack.us
Were looking to learn more about who uses GovTrack and what features you find helpful or think could be improved. If you can, please take a few minutes to help us improve GovTrack for users like you. Im a lobbyist, advocate, or other professional. Im a young person (younger than 26 years old). Im a member of a minority or disadvantaged group. Im a teacher, librarian, or other educator. We hope to make GovTrack more useful to policy professionals like you. Please sign up for our advisory group to be a part of making GovTrack a better tool for what you do. Young Americans have historically been the least involved in politics, despite the huge consequences policies can have on them. By joining our advisory group, you can help us make GovTrack more useful and engaging to young voters like you. Our mission is to empower every American with the tools to understand and impact Congress. We hope that with your input we can make GovTrack more accessible to minority and disadvantaged communities who we may currently struggle to reach. Please join our advisory group to let us know what more we can do. We love educating Americans about how their government works too! Please help us make GovTrack better address the needs of educators by joining our advisory group. Would you like to join our advisory group to work with us on the future of GovTrack? Thank you for joining the GovTrack Advisory Community! Well be in touch. Continue reading >>
- A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC’s National Diabetes Prevention Program
- Carmel Valley resident joins more than 180 diabetes advocates for the American Diabetes Associations 2017 Call to Congress Advocacy Day
- American Diabetes Association calls on Congress to hold hearings on insulin prices
New Diabetes Commission Goals
What the New National Diabetes Commission Will Try to Accomplish Written by Ginger Vieira on November 27, 2017 The 11-member commission will try to coordinate federal programs, as well as determine which ones should be eliminated or modified. In early November, a bill establishing the National Clinical Care Commission Act was signed into law by President Trump. Originally written by New Hampshire Senators Susan Collins and Jeanne Shaheen, this bill is designed to improve diabetes treatment, education, research, and prevention throughout the nation. Even despite statistics from the American Diabetes Association that 30 million adults and children in the United States have diabetes and another 1.4 million are diagnosed with it every year. Offices on Capitol Hill were generally surprised to learn that one out of every three Medicare dollars is spent on people with diabetes, Sara Milo, director of Legislation and Governmental Affairs at the American Association of Clinical Endocrinologists (AACE) , told Healthline. Milo and her staff at AACE were vital to the creation of the commission. Additionally, explained Milo, most offices didnt realize how severely diabetes care is actually affecting the federal health programs already in place. The federal government was not coordinating its efforts with the 30 or more federal agencies involved in diabetes activities to make an impact on the care of people with diabetes, she said. There was a recognition that the current regulatory structure was not working as well as it should and it needed to be addressed. The new commission of experts will be supported through existing funding already allocated to the Department of Health and Human Services. It consists of 11 members from these federal agencies: Centers for Disease Control and P Continue reading >>
